Senate Judiciary Advances Drug Patent Reform, FDA-PTO Bills To Floor

By Gabrielle Wanneh / February 9, 2023 at 2:55 PM
The Senate Judiciary Committee on Thursday (Feb. 9) voted to advance five bipartisan bills aimed at lowering prescription drug costs by reforming the drug patent system and fostering more collaboration between FDA and the U.S. Patent and Trademark Office (USPTO) to the Senate floor, despite concerns raised by some lawmakers over the bills’ potential to complicate current patent law. The following is a rundown of the bills, four of which have been pending in Congress for some time. The Interagency...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.